Cargando…
Flcn-deficient renal cells are tumorigenic and sensitive to mTOR suppression
Deficiency of tumor suppressor FLCN leads to the activation of the mTOR signaling pathway in human BHD-associated renal cell carcinomas (RCC). We have previously developed a renal distal tubule-collecting duct-Henle's loop-specific Flcn knockout (KO) mouse model (Flcn(flox/flox)/Ksp-Cre). This...
Autores principales: | Wu, Mingsong, Si, Shuhui, Li, Yan, Schoen, Susan, Xiao, Guang-Qian, Li, Xueying, Teh, Bin Tean, Wu, Guan, Chen, Jindong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741728/ https://www.ncbi.nlm.nih.gov/pubmed/26418749 |
Ejemplares similares
-
Deficiency of FLCN in Mouse Kidney Led to Development of Polycystic Kidneys and Renal Neoplasia
por: Chen, Jindong, et al.
Publicado: (2008) -
Correction: Deficiency of FLCN in Mouse Kidney Led to Development of Polycystic Kidneys and Renal Neoplasia
por: Chen, Jindong, et al.
Publicado: (2008) -
Correction: Deficiency of FLCN in Mouse Kidney Led to Development of Polycystic Kidneys and Renal Neoplasia
por: Chen, Jindong, et al.
Publicado: (2008) -
The tumor suppressor FLCN mediates an alternate mTOR pathway to regulate browning of adipose tissue
por: Wada, Shogo, et al.
Publicado: (2016) -
Suppression of autophagy enhances preferential toxicity of paclitaxel to folliculin-deficient renal cancer cells
por: Zhang, Qi, et al.
Publicado: (2013)